دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Incidence of Atherosclerotic Cardiovascular Disease in Young Adults at Low Short-Term But High Long-Term Risk
Jaejin An, PH D, a,b Yiyi Zhang, P HD, c Hui Zhou, PHD, a,b Mengnan Zhou, BS, a Monika M. Safford, MD,d Paul Muntner, PH D, e Andrew E. Moran, MD, MPH,c Kristi Reynolds, PHD
doi : 10.1016/j.jacc.2022.11.051
Volume 81, Issue 7, 21 February 2023, Pages 623-632
Young adults may have high long-term atherosclerotic cardiovascular disease (ASCVD) risk despite low short-term risk.
Cardiovascular Risk Assessment and Prevention Across the Life Course: Propensity, Determinants, Risk, Disease∗
Donald M. Lloyd-Jones, MD, SC M,a,b,c John T. Wilkins, MD, MS
doi : 10.1016/j.jacc.2022.12.007
Volume 81, Issue 7, 21 February 2023, Pages 633-635
Risk of Surgical Mitral Valve Repair for Primary Mitral Regurgitation
Vinay Badhwar, MD, a Joanna Chikwe, MD, b A. Marc Gillinov, MD,c Sreek Vemulapalli, MD,d Patrick T. O’Gara, MD, e J. Hunter Mehaffey, MD, MS C,a Moritz Wyler von Ballmoos, MD, PHD, f Michael E. Bowdish, MD, MS,b Elizabeth L. Gray, MS, g Sean M. O’Brien, P HD, h Vinod H. Thourani, MD, i David M. Shahian, MD,j Robert H. Habib, PH D
doi : 10.1016/j.jacc.2022.11.017
Volume 81, Issue 7, 21 February 2023, Pages 636-648
Risk estimation for surgical intervention is an essential component of heart team shared decision-making. However, current mitral valve (MV) surgery risk models used in practice lack etiologic or procedural specificity.
Benchmarking Mitral Valve Repair: Defining Standards for Surgical and Percutaneous Treatment of Severe Mitral Regurgitation∗
Anelechi C. Anyanwu, MD, David H. Adams, MD
doi : 10.1016/j.jacc.2023.01.001
Volume 81, Issue 7, 21 February 2023, Pages 649-652
Left Ventricular Filling Pressure in Chronic Thromboembolic Pulmonary Hypertension
Christian Gerges, MD, P HD, a Anna-Maria Pistritto, MD, b Mario Gerges, MD,c Richard Friewald, MD,d,e Valerie Hartig, a Thomas M. Hofbauer, MD, PHD, a Benedikt Reil, a Leon Engel, a Varius Dannenberg, MD,a Stefan P. Kastl, MD, PH D, a Nika Skoro-Sajer, MD, a Bernhard Moser, MD, f Shahrokh Taghavi, MD,f Walter Klepetko, MD,f Irene M. Lang, MD
doi : 10.1016/j.jacc.2022.11.049
Volume 81, Issue 7, 21 February 2023, Pages 653-664
Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by obstruction of major pulmonary arteries with organized thrombi. Clinical risk factors for pulmonary hypertension due to left heart disease including metabolic syndrome, left-sided valvular heart disease, and ischemic heart disease are common in CTEPH patients.
Association of Left Ventricular Filling Pressure With Chronic Thromboembolic Pulmonary Hypertension: A Matter of Perspective∗
Paul R. Forfia, MD
doi : 10.1016/j.jacc.2022.12.012
Volume 81, Issue 7, 21 February 2023, Pages 665-667
Association Between Number of Volunteer Responders and Interventions Before Ambulance Arrival for Cardiac Arrest
Mads Christian Tofte Gregers, MD,a,b Linn Andelius, MD, PHD, a Julie Samsoee Kjoelbye, MD,a,b Anne Juul Grabmayr, MD, a,b Louise Kollander Jakobsen, MD, a,b Nanna Bo Christensen, BS C ,a,b Astrid Rolin Kragh, MS C,a,b Carolina Malta Hansen, MD, PHD, a,c Rasmus Meyer Lyngby, a Ulla Væggemose, MSC , BA, P HD, d,e Christian Torp-Pedersen, MD, PH D, f,g Annette Kjær Ersbøll, MS C, P HD, h Fredrik Folke, MD, P HD
doi : 10.1016/j.jacc.2022.11.047
Volume 81, Issue 7, 21 February 2023, Pages 668-680
Volunteer responder (VR) programs for activation of laypersons in out-of-hospital cardiac arrest (OHCA) have been deployed worldwide, but the optimal number of VRs to dispatch is unknown.
Volunteer Response for Out-of-Hospital Cardiac Arrest: Strength in Numbers?∗
Sheldon Cheskes, MD
doi : 10.1016/j.jacc.2022.11.048
Volume 81, Issue 7, 21 February 2023, Pages 681-683
Bleeding Events After Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review
Marisa Avvedimento, MD, Jorge Nuche, MD, P HD, Julio I. Farjat-Pasos, MD, MS C, Josep Rodés-Cabau, MD, P HD
doi : 10.1016/j.jacc.2022.11.050
Volume 81, Issue 7, 21 February 2023, Pages 684-702
Transcatheter aortic valve replacement (TAVR) has gained over time a major reduction in procedural complications. Despite this, clinically relevant bleeding still occurs in a non-negligible proportion of patients and adversely affects prognosis.
Overturning Roe v. Wade: Increased Prevalence and Economic Impacts of Congenital Cardiac Defects
Ashwin Palaniappan, BA, a David Blitzer, MD, b Emile A. Bacha, MD, b Brett R. Anderson, MD, MBA, MS
doi : 10.1016/j.jacc.2022.11.046
Volume 81, Issue 7, 21 February 2023, Pages 703-704
Address Cardiovascular Health in Middle Age: Time to Remove the Blindfold
Valentin Fuster, MD PH D, Editor-in-Chief, Journal of the American College of Cardiology Borja Ibanez, MD, PHD, Director of Clinical Research, National Center for Cardiovascular Research (CNIC)
doi : 10.1016/j.jacc.2023.01.004
Volume 81, Issue 7, 21 February 2023, Pages 705-707
Right Ventricular Reverse Remodeling After Transcatheter Tricuspid Valve Replacement in Patients With Heart Failure
Ludwig T. Weckbach, MD Lukas Stolz, MD Andrew G. Chatfield, MD Neil P. Fam, MD Ralph Stephan von Bardeleben, MD Charles J. Davidson, MD Rebecca T. Hahn, MD Jörg Hausleiter, MD
doi : 10.1016/j.jacc.2022.12.005
Volume 81, Issue 7, 21 February 2023, Pages 708-710
